Recent Strategies to Develop Polysaccharide‐Based Nanomaterials for Biomedical Applications
Identifieur interne : 000173 ( Istex/Checkpoint ); précédent : 000172; suivant : 000174Recent Strategies to Develop Polysaccharide‐Based Nanomaterials for Biomedical Applications
Auteurs : Yifen Wen [Canada] ; Jung Kwon Oh [Canada]Source :
- Macromolecular Rapid Communications [ 1022-1336 ] ; 2014-11.
Abstract
Polysaccharides are abundant in nature, renewable, nontoxic, and intrinsically biodegradable. They possess a high level of functional groups including hydroxyl, amino, and carboxylic acid groups. These functional groups can be utilized for further modification of polysaccharides with small molecules, polymers, and crosslinkers; the modified polysaccharides have been used as effective building blocks in fabricating novel biomaterials for various biomedical applications such as drug delivery carriers, cell‐encapsulating biomaterials, and tissue engineering scaffolds. This review describes recent strategies to modify polysaccharides for the development of polysaccharide‐based biomaterials; typically self‐assembled micelles, crosslinked microgels/nanogels, three‐dimensional hydrogels, and fibrous meshes. In addition, the outlook is briefly discussed on the important aspects for the current and future development of polysaccharide‐based biomaterials, particularly tumor‐targeting intracellular drug delivery nanocarriers.
Modified polysaccharides are used as effective building blocks for fabricating novel biomaterials, typically self‐assembled micelles, crosslinked microgels/nanogels, three‐dimensional hydrogels, and fibrous meshes for various biomedical applications, such as drug delivery carriers, cell‐encapsulating biomaterials, and tissue engineering scaffolds.
Url:
DOI: 10.1002/marc.201400406
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:B2EF9696D71902EE41F036B3C0DA4F2EF96D275FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recent Strategies to Develop Polysaccharide‐Based Nanomaterials for Biomedical Applications</title>
<author><name sortKey="Wen, Yifen" sort="Wen, Yifen" uniqKey="Wen Y" first="Yifen" last="Wen">Yifen Wen</name>
</author>
<author><name sortKey="Oh, Jung Kwon" sort="Oh, Jung Kwon" uniqKey="Oh J" first="Jung Kwon" last="Oh">Jung Kwon Oh</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B2EF9696D71902EE41F036B3C0DA4F2EF96D275F</idno>
<date when="2014" year="2014">2014</date>
<idno type="doi">10.1002/marc.201400406</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-B8RV84XD-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C66</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C66</idno>
<idno type="wicri:Area/Istex/Curation">001C66</idno>
<idno type="wicri:Area/Istex/Checkpoint">000173</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000173</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Recent Strategies to Develop Polysaccharide‐Based Nanomaterials for Biomedical Applications</title>
<author><name sortKey="Wen, Yifen" sort="Wen, Yifen" uniqKey="Wen Y" first="Yifen" last="Wen">Yifen Wen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, Concordia University, Quebec, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oh, Jung Kwon" sort="Oh, Jung Kwon" uniqKey="Oh J" first="Jung Kwon" last="Oh">Jung Kwon Oh</name>
<affiliation wicri:level="3"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, Concordia University, Quebec, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Canada</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Macromolecular Rapid Communications</title>
<title level="j" type="alt">MACROMOLECULAR RAPID COMMUNICATIONS</title>
<idno type="ISSN">1022-1336</idno>
<idno type="eISSN">1521-3927</idno>
<imprint><biblScope unit="vol">35</biblScope>
<biblScope unit="issue">21</biblScope>
<biblScope unit="page" from="1819">1819</biblScope>
<biblScope unit="page" to="1832">1832</biblScope>
<biblScope unit="page-count">14</biblScope>
<date type="published" when="2014-11">2014-11</date>
</imprint>
<idno type="ISSN">1022-1336</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1022-1336</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Polysaccharides are abundant in nature, renewable, nontoxic, and intrinsically biodegradable. They possess a high level of functional groups including hydroxyl, amino, and carboxylic acid groups. These functional groups can be utilized for further modification of polysaccharides with small molecules, polymers, and crosslinkers; the modified polysaccharides have been used as effective building blocks in fabricating novel biomaterials for various biomedical applications such as drug delivery carriers, cell‐encapsulating biomaterials, and tissue engineering scaffolds. This review describes recent strategies to modify polysaccharides for the development of polysaccharide‐based biomaterials; typically self‐assembled micelles, crosslinked microgels/nanogels, three‐dimensional hydrogels, and fibrous meshes. In addition, the outlook is briefly discussed on the important aspects for the current and future development of polysaccharide‐based biomaterials, particularly tumor‐targeting intracellular drug delivery nanocarriers.</div>
<div type="abstract" xml:lang="en">Modified polysaccharides are used as effective building blocks for fabricating novel biomaterials, typically self‐assembled micelles, crosslinked microgels/nanogels, three‐dimensional hydrogels, and fibrous meshes for various biomedical applications, such as drug delivery carriers, cell‐encapsulating biomaterials, and tissue engineering scaffolds.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Québec</li>
</region>
<settlement><li>Montréal</li>
</settlement>
</list>
<tree><country name="Canada"><region name="Québec"><name sortKey="Wen, Yifen" sort="Wen, Yifen" uniqKey="Wen Y" first="Yifen" last="Wen">Yifen Wen</name>
</region>
<name sortKey="Oh, Jung Kwon" sort="Oh, Jung Kwon" uniqKey="Oh J" first="Jung Kwon" last="Oh">Jung Kwon Oh</name>
<name sortKey="Oh, Jung Kwon" sort="Oh, Jung Kwon" uniqKey="Oh J" first="Jung Kwon" last="Oh">Jung Kwon Oh</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000173 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000173 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:B2EF9696D71902EE41F036B3C0DA4F2EF96D275F |texte= Recent Strategies to Develop Polysaccharide‐Based Nanomaterials for Biomedical Applications }}
This area was generated with Dilib version V0.6.33. |